Repeated annual influenza vaccination and vaccine effectiveness: review of evidence

ABSTRACT Introduction: Studies in the 1970s and 1980s signaled concern that repeated influenza vaccination could affect vaccine protection. The antigenic distance hypothesis provided a theoretical framework to explain variability in repeat vaccination effects based on antigenic similarity between successive vaccine components and the epidemic strain. Areas covered: A meta-analysis of vaccine effectiveness studies from 2010–11 through 2014–15 shows substantial heterogeneity in repeat vaccination effects within and between seasons and subtypes. When negative effects were observed, they were most pronounced for H3N2, especially in 2014–15 when vaccine components were unchanged and antigenically distinct from the epidemic strain. Studies of repeated vaccination across multiple seasons suggest that vaccine effectiveness may be influenced by more than one prior season. In immunogenicity studies, repeated vaccination blunts the hemagglutinin antibody response, particularly for H3N2. Expert commentary: Substantial heterogeneity in repeated vaccination effects is not surprising given the variation in study populations and seasons, and the variable effects of antigenic distance and immunological landscape in different age groups and populations. Caution is required in the interpretation of pooled results across multiple seasons, since this can mask important variation in repeat vaccination effects between seasons. Multi-season clinical studies are needed to understand repeat vaccination effects and guide recommendations.

[1]  Nicholas S. Kelley,et al.  Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. , 2016, The Lancet. Infectious diseases.

[2]  J. McDonald,et al.  Diagnostic Methods in an Influenza Vaccine Trial* , 1955, British medical journal.

[3]  L. Burney Influenza immunization: Statement. , 1960, Public health reports.

[4]  S. Lindstrom,et al.  Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results. , 2011, Vaccine.

[5]  A. Monto,et al.  2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[7]  D. Skowronski,et al.  A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014–2015 Season , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  A. Monto,et al.  Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Christine Miller,et al.  ASSESSMENT OF INACTIVATED INFLUENZA-A VACCINE AFTER THREE OUTBREAKS OF INFLUENZA A AT CHRIST'S HOSPITAL , 1979, The Lancet.

[10]  J. Katz,et al.  Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11. , 2016, Vaccine.

[11]  S. Kent,et al.  Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity , 2015, Expert review of vaccines.

[12]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[13]  Kui-biao Li,et al.  Concurrent and cross-season protection of inactivated influenza vaccine against A(H1N1)pdm09 illness among young children: 2012-2013 case-control evaluation of influenza vaccine effectiveness. , 2015, Vaccine.

[14]  R. Greenlee,et al.  Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. , 2009, The Journal of infectious diseases.

[15]  M. D. Eaton,et al.  AN ANALYSIS OF SEROLOGICAL REACTIONS AFTER VACCINATION AND INFECTION WITH THE VIRUS OF INFLUENZA A , 1942 .

[16]  A. Monto,et al.  Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination. , 2015, The Journal of infectious diseases.

[17]  D. Skowronski,et al.  Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season. , 2015, The Journal of infectious diseases.

[18]  A. Osterhaus,et al.  Annual influenza vaccination affects the development of heterosubtypic immunity. , 2012, Vaccine.

[19]  W. Ndifon A simple mechanistic explanation for original antigenic sin and its alleviation by adjuvants , 2015, Journal of The Royal Society Interface.

[20]  A. Monto,et al.  Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. , 2016, The Journal of infectious diseases.

[21]  Christine Miller,et al.  INFLUENZA AT CHRIST'S HOSPITAL: MARCH, 1974 , 1976, The Lancet.

[22]  John S. Tsang,et al.  Utilizing population variation, vaccination, and systems biology to study human immunology , 2015, Trends in immunology.

[23]  A D LANGMUIR,et al.  THE EPIDEMIOLOGICAL BASIS FOR THE CONTROL OF INFLUENZA. , 1964, American journal of public health and the nation's health.

[24]  D. Skowronski,et al.  Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v). , 2012, The Journal of infectious diseases.

[25]  Florian Krammer,et al.  Neutralizing Antibodies Against Previously Encountered Influenza Virus Strains Increase over Time: A Longitudinal Analysis , 2013, Science Translational Medicine.

[26]  T. Friedrich,et al.  Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  I. Julkunen,et al.  Effectiveness of Pandemic and Seasonal Influenza Vaccines in Preventing Laboratory-Confirmed Influenza in Adults: A Clinical Cohort Study during Epidemic Seasons 2009–2010 and 2010–2011 in Finland , 2014, PloS one.

[28]  A S Perelson,et al.  Variable efficacy of repeated annual influenza vaccination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  W Carman,et al.  Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom , 2012, Epidemiology and Infection.

[30]  A. Osterhaus,et al.  Annual Vaccination against Influenza Virus Hampers Development of Virus-Specific CD8+ T Cell Immunity in Children , 2011, Journal of Virology.

[31]  A. Monto,et al.  Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015. , 2016, The Journal of infectious diseases.

[32]  J. Davies,et al.  Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses , 1989, Epidemiology and Infection.

[33]  Jin Hyang Kim,et al.  Strategies to alleviate original antigenic sin responses to influenza viruses , 2012, Proceedings of the National Academy of Sciences.

[34]  D. Skowronski,et al.  Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. , 2014, The Journal of infectious diseases.

[35]  A. Monto,et al.  Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility. , 2015, The Journal of infectious diseases.

[36]  A. Monto,et al.  Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  F. Pozo,et al.  Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study. , 2012, Vaccine.

[38]  E. Belongia,et al.  Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort. , 2009, Vaccine.

[39]  R. Brunham,et al.  Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age. , 2011, The Journal of infectious diseases.

[40]  R B Couch,et al.  Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. , 1997, Vaccine.

[41]  G. Rimmelzwaan,et al.  Yearly influenza vaccinations: a double-edged sword? , 2009, The Lancet. Infectious diseases.

[42]  A. García-Sastre Systems vaccinology informs influenza vaccine immunogenicity , 2016, Proceedings of the National Academy of Sciences.

[43]  E. Hak,et al.  2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[44]  Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004-2005. , 2005, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[45]  Richard K. Zimmerman,et al.  Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type , 2014, The Journal of infectious diseases.

[46]  C. A. Russell,et al.  Antibody landscapes after influenza virus infection or vaccination , 2014, Science.

[47]  J. Castilla,et al.  Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010–2011: a population-based test-negative case–control study , 2013, BMC Public Health.

[48]  K. Davis,et al.  The Split Virus Influenza Vaccine rapidly activates immune cells through Fcγ receptors. , 2014, Vaccine.

[49]  B. Cowling,et al.  Influenza vaccine effectiveness in the community and the household. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[50]  D. Skowronski,et al.  A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[51]  T. Hoskins,et al.  Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain. , 1973, Lancet.

[52]  E. Pariani,et al.  Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/15 season. , 2016, Vaccine.

[53]  M. Valenciano,et al.  Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15. , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[54]  A. Monto,et al.  Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated. , 2016, The Journal of infectious diseases.

[55]  Judith M. Fonville,et al.  The confounded effects of age and exposure history in response to influenza vaccination. , 2016, Vaccine.

[56]  R. Compans,et al.  Original Antigenic Sin Responses to Influenza Viruses1 , 2009, The Journal of Immunology.

[57]  S. Halstead,et al.  The Wages of Original Antigenic Sin , 2010, Emerging infectious diseases.

[58]  I. Longini,et al.  Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981. , 1985, American journal of epidemiology.

[59]  Suresh Mahalingam,et al.  Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes , 2010, The Lancet Infectious Diseases.

[60]  D. Skowronski,et al.  Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses , 2014, PloS one.

[61]  F. Pozo,et al.  Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons. , 2016, Vaccine.